Exercise Training for Long COVID Symptoms

Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity

Recruiting N/A Interventional Study
Post-acute Sequelae of SARS-CoV-2 Infection
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
University of Colorado, Denver · Other
Who this trial is looking for

This trial is looking for adults who have had COVID-19 and are experiencing symptoms lasting more than 12 weeks. Participants will take part in exercise training to see if it helps improve their condition.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 18 years old
  • I have a documented history of COVID-19 infection
  • I have symptoms that are consistent with Long COVID
  • My symptoms have lasted more than 12 weeks after my diagnosis

You may not be able to join if

  • I have had cardiovascular or pulmonary disease before COVID-19
  • I have had heart issues related to COVID-19
  • I have had deep vein thrombosis or pulmonary embolism after COVID-19
  • I have exercise intolerance that is not linked to my heart or lungs
  • I need supplemental oxygen because of heart or lung problems after COVID-19

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The primary objectives of this study are to determine whether exercise training is an effective strategy for treatment of Long COVID and characterize the cardiorespiratory and autonomic physiology in these patients to precisely characterize mechanisms contributing to this syndrome.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults ≥18 years with documented history of COVID-19 infection and symptoms consistent with Long COVID lasting \>12 weeks after diagnosis. Exclusion Criteria: * History of cardiovascular/pulmonary disease prior to infection * COVID-related myocardial injury such as evidence …
Contacts

William K Cornwell, III, MD

303-724-2085

william.cornwell@cuanschutz.edu

CONTACT